| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.092 | 0.6 |